
About Composite Interceptive Med-Science Laboratories Private Limited
Data last updated:
Composite Interceptive Med-Science Laboratories Private Limited is a private limited company based in Bengaluru, Karnataka, India, recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 05 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2018PTC109264. Its GSTIN is 29AAHCC3551C1ZV (Karnataka).
The company has an authorised share capital of ₹5.1 Cr and a paid-up capital of ₹2.07 Cr. It is led by directors Samarth Shetty and Paul Christadas Salins.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd Floor Pragati Plaza Opp Biocon Housur Main Road Hebbagodi, Bengaluru, Karnataka, India – 560099.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.34 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹2.23 Cr and EBITDA of -₹1.1 Cr. Revenue has declined at a compounded annual rate (CAGR) of 26% over three years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: CIMED.
For more details, the company can be reached via its website cimedlife.com.
Company details
Recognitions & Rankings of Composite Interceptive Med-Science Laboratories
Contact details
Composite Interceptive Med-Science Laboratories Private Limited's registered office is in Bengaluru, Karnataka.
- Registered Address2nd Floor Pragati Plaza Opp Biocon Housur Main Road Hebbagodi, Bengaluru, Karnataka, India – 560099
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Composite Interceptive Med-Science Laboratories operates one associated brand: CIMED. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A CRO specializing in therapeutics and chronic disease management through innovative solutions. | cimedlife.com |
Business activity
The main business activity of Composite Interceptive Med-Science Laboratories is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Composite Interceptive Med-Science Laboratories Private Limited, buy the company report.
Financials of Composite Interceptive Med-Science Laboratories Private Limited
FY 2025 filings availableComposite Interceptive Med-Science Laboratories Private Limited reported revenue of ₹19.34 Lakh (down 64% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 26% over three years, including a 64% fall in the latest year. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Composite Interceptive Med-Science Laboratories Private Limited, buy the company report.
Board of directors of Composite Interceptive Med-Science Laboratories Private Limited
Composite Interceptive Med-Science Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samarth Shetty | Director | 25 Aug 2025 | 1 Years 2 Months | Current |
| Paul Christadas Salins | Director | 05 Jan 2018 | 8 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Composite Interceptive Med-Science Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Composite Interceptive Med-Science Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Composite Interceptive Med-Science Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCC3551C1ZV | Karnataka | Active | 08 Feb 2018 |
To see the full GST registrations and return filing status of Composite Interceptive Med-Science Laboratories Private Limited, buy the company report.
Recent activity
Composite Interceptive Med-Science Laboratories Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Neelakantha Karinje ceased to be Director on 25 Aug 2025.
News
Frequently asked questions
Composite Interceptive Med-Science Laboratories is an active private limited company based in Bengaluru, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 05 January 2018 (8+ years old) and is registered under CIN U73100KA2018PTC109264.
Composite Interceptive Med-Science Laboratories has 2 current directors:
- Samarth Shetty - Director
- Paul Christadas Salins - Director
The latest financial statements of Composite Interceptive Med-Science Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Composite Interceptive Med-Science Laboratories is 29AAHCC3551C1ZV, registered in Karnataka.
The CIN (Corporate Identification Number) of Composite Interceptive Med-Science Laboratories is U73100KA2018PTC109264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Composite Interceptive Med-Science Laboratories was incorporated on 05 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Neelakantha Karinje ceased to be Director on 25 Aug 2025. Samarth Shetty was appointed as Director on 25 Aug 2025. Vikash ceased to be Additional Director on 04 Apr 2020. Composite Interceptive Med-Science Laboratories has 6 board changes on record in total.
Yes, Composite Interceptive Med-Science Laboratories is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Composite Interceptive Med-Science Laboratories can be reached through the website cimedlife.com. Its registered office is in Bengaluru, Karnataka, India.
The registered office of Composite Interceptive Med-Science Laboratories is at 2nd Floor Pragati Plaza Opp Biocon Housur Main Road Hebbagodi, Bengaluru, Karnataka, India – 560099.

